Brief: CK Life Sciences Intl (Holdings) Posts FY Profit Attributable Of HK$258 Mln
March 13 (Reuters) - Ck Life Sciences Intl (Holdings) Inc
0775.HK :
* BOARD OF DIRECTORS HAS RECOMMENDED A FINAL DIVIDEND OF
HK$0.01
PER SHARE
* FY PROFIT ATTRIBUTABLE HK$258 MILLION, AN INCREASE OF 2%
* FY REVENUE HK$4.69 BILLION VERSUS HK$4.87 BILLION
Source text for Eikon: ID:nHKS4ZMMfd
Further company coverage: 0775.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CK Life Sciences Intl (Holdings)
See all newsCK Life Sciences H1 loss narrows on lower R&D costs
Brief: CK Life Sciences Intl Announces Resignation Of Lance Richard Lee Yuen As Executive Director, CEO
Brief: CK Life Sciences Intl Logs FY Loss Attributable HK$186.8 Mln
CK Life Sciences rises most in 4 months on advancing cancer vaccine development
Brief: CK Life Sciences Intl Establishes Sequencio Therapeutics For Cancer Vaccine Development